SHELBY ELDER: Open Payments
NPI 1205333424 · HAHIRA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 12 payments from 7 companies in 2025. Trend: 2023 $556 · 2024 $903 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $76 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Alkermes, Inc. | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
Products named: CAPLYTA, FANAPT, Auvelity, VRAYLAR, LYBALVI, ARISTADA, REXULTI, Qelbree.
Industry payments across GA — which companies pay providers there.
